About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
AORT
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Artivion Non-GAAP EPS of $0.02 beats by $0.04, revenue of $83.2M beats by $2.85M
- Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M
- Artivion Non-GAAP EPS of -$0.05, revenue of $76.8M
- Artivion stock falls as apixaban fails vs warfarin in reducing blood clots in aortic valve patients; reaffirms outlook
- Artivion Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $80.34M beats by $3.07M
- Artivion Non-GAAP EPS of $0.03, revenue of $77.2M
- CryoLife's director buy shares
- CryoLife EPS misses by $0.06, misses on revenue
- CryoLife adds Anthony Semedo to board of directors
- CryoLife EPS beats by $0.05, beats on revenue
- CryoLife EPS misses by $0.07, beats on revenue
- CryoLife EPS beats by $0.17, beats on revenue
- Greenlight takes fresh stakes in Twitter, Intel; exits Whirlpool, Tempur Sealy
- CryoLife EPS beats by $0.17, beats on revenue
- CryoLife announces acquisition of aortic repair device developer
- Needham's medtech look sees continued gains through year-end, names picks
- CryoLife EPS beats by $0.07, beats on revenue
- CryoLife prices $100M convertible debt offering
- CryoLife launches convertible debt offering
- Needham weighs top picks as med techs recover